Atlas Trials

CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT03473496 · TERMINATED

Trial details

NCT number
NCT03473496
Sponsor
Zhujiang Hospital
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple Myeloma(MM)
Start date
2018-03-01
Primary completion
2020-01-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.